Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2026-05-29 @ 5:21 AM
Study NCT ID:
NCT03351361
Status:
COMPLETED
Last Update Posted:
2023-03-01
First Post:
2017-11-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients
Sponsor:
Rennes University Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Non Small Cell Lung Cancer | View |
Keywords: